288 related articles for article (PubMed ID: 12078948)
1. The mature form of adrenomedullin correlates with brain natriuretic peptide in plasma of chronic hemodialysis patients.
Suda T; Osajima A; Iwamoto M; Anai H; Tamura M; Kabashima N; Ota T; Watanabe Y; Kanegae K; Okazaki M; Nakashima Y
Clin Nephrol; 2002 Jun; 57(6):444-51. PubMed ID: 12078948
[TBL] [Abstract][Full Text] [Related]
2. Comparison of plasma levels of mature adrenomedullin and natriuretic peptide as markers of cardiac function in hemodialysis patients with coronary artery disease.
Osajima A; Okazaki M; Tamura M; Anai H; Kabashima N; Suda T; Iwamoto M; Ota T; Watanabe Y; Kanegae K; Nakashima Y
Nephron; 2002 Dec; 92(4):832-9. PubMed ID: 12399629
[TBL] [Abstract][Full Text] [Related]
3. Increased plasma levels of mature form of adrenomedullin in patients with chronic renal failure.
Ishihara T; Yokota N; Hisanaga S; Fujimoto S; Hirayama N; Kato J; Kitamura K; Eto T
Clin Nephrol; 1999 Aug; 52(2):119-23. PubMed ID: 10480223
[TBL] [Abstract][Full Text] [Related]
4. Adrenomedullin reflects cardiac dysfunction, excessive blood volume, and inflammation in hemodialysis patients.
Yoshihara F; Horio T; Nakamura S; Yoshii M; Ogata C; Nakahama H; Inenaga T; Kangawa K; Kawano Y
Kidney Int; 2005 Sep; 68(3):1355-63. PubMed ID: 16105071
[TBL] [Abstract][Full Text] [Related]
5. Plasma concentration of human brain natriuretic peptide in patients on hemodialysis.
Ishizaka Y; Yamamoto Y; Fukunaga T; Yokota N; Kida O; Kitamura K; Kangawa K; Minamino N; Matsuo H; Eto T
Am J Kidney Dis; 1994 Sep; 24(3):461-72. PubMed ID: 8079971
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease.
Osajima A; Okazaki M; Kato H; Anai H; Tsuda Y; Segawa K; Tanaka H; Tamura M; Takasugi M; Nakashima Y
Am J Nephrol; 2001; 21(2):112-9. PubMed ID: 11359018
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of adrenomedullin and atrial and brain natriuretic peptides in the general population: their relations to age and pulse pressure.
Kato J; Kitamura K; Uemura T; Kuwasako K; Kita T; Kangawa K; Eto T
Hypertens Res; 2002 Nov; 25(6):887-92. PubMed ID: 12484513
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels of mature form of adrenomedullin in patients with haemodialysis.
Tokura T; Kinoshita H; Fujimoto S; Hisanaga S; Kitamura K; Eto T
Nephrol Dial Transplant; 2001 Apr; 16(4):783-6. PubMed ID: 11274274
[TBL] [Abstract][Full Text] [Related]
9. Molecular forms of human brain natriuretic peptide (BNP) in plasma of patients on hemodialysis (HD).
Ishizaka Y; Yamamoto Y; Tanaka M; Kato F; Ishizaka Y; Yokota N; Kato J; Kitamura K; Eto T; Kangawa K
Clin Nephrol; 1995 Apr; 43(4):237-42. PubMed ID: 7606877
[TBL] [Abstract][Full Text] [Related]
10. Plasma brain natriuretic peptide levels in chronic hemodialysis patients: influence of coronary artery disease.
Nishikimi T; Futoo Y; Tamano K; Takahashi M; Suzuki T; Minami J; Honda T; Uetake S; Asakawa H; Kobayashi N; Horinaka S; Ishimitsu T; Matsuoka H
Am J Kidney Dis; 2001 Jun; 37(6):1201-8. PubMed ID: 11382689
[TBL] [Abstract][Full Text] [Related]
11. Changes in brain natriuretic peptide and atrial natriuretic peptide plasma concentrations during hemodialysis in patients with chronic renal failure.
Haug C; Metzele A; Steffgen J; Grünert A
Horm Metab Res; 1994 May; 26(5):246-9. PubMed ID: 8076909
[TBL] [Abstract][Full Text] [Related]
12. Plasma adrenomedullin and natriuretic peptides in patients with essential or malignant hypertension.
Kato J; Kitamura K; Matsui E; Tanaka M; Ishizaka Y; Kita T; Kangawa K; Eto T
Hypertens Res; 1999 Mar; 22(1):61-5. PubMed ID: 10221353
[TBL] [Abstract][Full Text] [Related]
13. [Effects of long-term treatment with prostacyclin on plasma adrenomedullin in patients with primary pulmonary hypertension].
Nakayama T; Ishikita T; Matsuura H; Saji T
J Cardiol; 2001 Nov; 38(5):263-71. PubMed ID: 11729726
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of proadrenomedullin N-terminal 20 peptide and adrenomedullin in patients undergoing hemodialysis.
Tokura T; Kinoshita H; Fujimoto S; Kitamura K; Eto T
Nephron Clin Pract; 2003; 95(2):c67-72. PubMed ID: 14610332
[TBL] [Abstract][Full Text] [Related]
15. Plasma adrenomedullin levels in patients on hemodialysis.
Yamasaki H; Nagake Y; Akagi S; Sugimoto T; Ichikawa H; Makino H
Nephron; 2001 Sep; 89(1):20-5. PubMed ID: 11528227
[TBL] [Abstract][Full Text] [Related]
16. Relationship between Doppler transmitral flow velocity pattern and plasma atrial and brain natriuretic peptide concentrations in anuric patients on maintenance hemodialysis.
Ito S; Murai S; Takada N; Ozasa A; Hanada M; Sugiyama M; Suzuki K; Nagae Y; Inagaki T; Takeda Y; Fukutomi T; Joh T
Int Heart J; 2006 May; 47(3):401-8. PubMed ID: 16823246
[TBL] [Abstract][Full Text] [Related]
17. Increased brain natriuretic peptide and atrial natriuretic peptide plasma concentrations in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure.
Haug C; Metzele A; Steffgen J; Kochs M; Hombach V; Grünert A
Clin Investig; 1994 Jun; 72(6):430-4. PubMed ID: 7950153
[TBL] [Abstract][Full Text] [Related]
18. Plasma concentrations of natriuretic peptides in patients on hemodialysis.
Takahashi M; Nagake Y; Ichikawa H; Kawabata K; Nakazono H; Hirata K; Ogura T; Makino H
Res Commun Mol Pathol Pharmacol; 1996 Apr; 92(1):19-30. PubMed ID: 8733825
[TBL] [Abstract][Full Text] [Related]
19. Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in chronic renal failure.
Pedersen EB; Bacevicius E; Bech JN; Solling K; Pedersen HB
Clin Sci (Lond); 2006 Apr; 110(4):491-501. PubMed ID: 16396628
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of cardiac natriuretic peptides measured by means of competitive and non-competitive immunoassay methods in patients with renal failure on chronic hemodialysis.
Clerico A; Caprioli R; Del Ry S; Giannessi D
J Endocrinol Invest; 2001 Jan; 24(1):24-30. PubMed ID: 11227728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
